Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcturus Therapeutics Holdings Inc. logo

Chief Financial Officer Sassine Andy sold $1,601,500 worth of shares (50,000 units at $32.03), decreasing direct ownership by 18% to 220,526 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARCT· Arcturus Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARCT (Arcturus Therapeutics Holdings Inc.) and more on Quantisnow.